About Eyerising International
An Australian-based MedTech company pioneering repeated low-level red-light technology for childhood myopia management.
Who We Are
Eyerising International is an Australian MedTech company developing RLRL therapy for the management of childhood myopia in patients aged 3–16 years old. Our work is guided by leading ophthalmology researchers and clinicians, with a focus on innovation, implementation, and clinical validation.
The Eyerising Myopia Management Device delivers RLRL therapy, and was conceived and developed by our Chief Medical Officer, Professor Mingguang He—a globally recognised researcher in myopia control and the development of artificial intelligence systems in ophthalmology.
The device is patented and registered on the Australian Register of Therapeutic Goods (ARTG 412752). Today, Eyerising International operates across more than 30 countries, partnering with eye-care professionals worldwide.
Eyerising International is an Australian MedTech company dedicated to innovation in children's vision. Our work is guided by experts in ophthalmology, optometry, and medical technology.
Eyerising International has fostered partnerships with universities and research institutions worldwide, and our patented technology is listed on the Australian Register of Therapeutic Goods (ARTG 412752).
Today, we operate across more than 30 countries, working with eye-care professionals to deliver accessible, evidence-based myopia management to children and families globally.
What Drives Us
Innovation
We continuously advance RLRL technology, investing in research and development to improve outcomes for children with myopia and deliver a superior patient experience.
Clinical Excellence
Every decision we make is grounded in scientific evidence. We uphold the highest clinical standards across our research, regulatory submissions, and clinical partnerships.
Global Access
We believe every child deserves access to effective myopia management. Our global distribution network and partnerships with eye-care professionals make this vision a reality.
By the Numbers
30+
Countries
1,500+
Active Patients Internationally
80,000+
Patients Through Eyerising China
15+
Clinical Trials
Join Us in Advancing Myopia Management
Whether you are a clinician, distributor, or family seeking solutions, we would love to hear from you.
Contact Us